Accelrys, Inc. (ACCL) Tops Q1 EPS by 2c; Guides FY12 EPS, Revs
Tweet
Share
E-mailGet Alerts ACCL Hot Sheet
Price: $2.85 -1.38%
Financial Fact:
License and subscription revenue: 22.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
License and subscription revenue: 22.92M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Accelrys, Inc. (NASDAQ: ACCL) reported Q1 EPS of $0.08, $0.02 better than the analyst estimate of $0.06. Revenue for the quarter came in at $41.8 million versus the consensus estimate of $41 million.
Accelrys, Inc. sees FY2012 EPS of $0.32-$0.34, versus the consensus of $0.33. Accelrys, Inc. sees FY2012 revenue of $165-$170 million, versus the consensus of $167.54 million.
For earnings history and earnings-related data on Accelrys, Inc. (ACCL) click here.
Accelrys, Inc. sees FY2012 EPS of $0.32-$0.34, versus the consensus of $0.33. Accelrys, Inc. sees FY2012 revenue of $165-$170 million, versus the consensus of $167.54 million.
For earnings history and earnings-related data on Accelrys, Inc. (ACCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
